The invention describes HLA class II binding peptides encoded by the MAGE-A3
tumor associated gene, as well as nucleic acids encoding such peptides and antibodies
relating thereto. The peptides stimulate the activity and proliferation of CD4+
T lymphocytes. Methods and products also are provided for diagnosing and treating
conditions characterized by expression of the MAGE-A3 gene.